-
Recent Posts
- Avid Bioservices Announces Addition of Novel Bacteriophage Production System at Upcoming BIO Convention as Part of a Collaboration with Phage Pharmaceuticals
- California FDB Grants Drug Manufacturing License to Phage Pharmaceuticals
- Phage Pharmaceuticals to File Investigational New Drug (IND) Application Using Its Lead Drug Candidate, FGF-1, for a First-in-Class Indication to Repair Tympanic Membrane Perforations
- Phage Pharmaceuticals and Stamford Bioprocess Technologies Sign Letter of Intent
- Phage Pharmaceuticals Executes a Letter of Intent with Viva Biotech
Archives
Categories
Tag Archives: bacterial expression
California FDB Grants Drug Manufacturing License to Phage Pharmaceuticals
San Diego, California – Phage Pharmaceuticals, Inc., a manufacturer of therapeutic proteins, has received a drug manufacturing license from the California Department of Public Health, Food and Drug Branch (CA FDB). Prior to issuing the license the FDB inspected the … Continue reading
Phage Pharmaceuticals and Stamford Bioprocess Technologies Sign Letter of Intent
San Diego, CA, November 6, 2011 – Stamford Bioprocess Technologies and Phage Pharmaceuticals recently signed a Letter of Intent to provide mutual access to the companies’ complementary technologies and expertise. While Stamford has extensive experience in the production of biologic … Continue reading
Posted in News
Tagged bacterial expression, E. coli, protein manufacturing, protein production, recombinant
Leave a comment
Phage Pharmaceuticals Executes a Letter of Intent with Viva Biotech
Shanghai, People’s Republic of China, October 10, 2011 – Phage Pharmaceuticals announced plans at the BIO China International Conference to establish a joint venture to utilize Phage’s “Intelligent Protein” platform as well as to develop and market cosmeceuticals in China … Continue reading
Posted in News
Tagged anti-aging, bacterial expression, cosmetics, protein manufacturing, protein production, skincare
Leave a comment